Identification of clinically relevant genetic variation in immune-mediated inflammatory diseases using genome-wide approaches

Rheumatoid arthritis, psoriasis, psoriatic arthritis, systemic lupus erythematosus, Crohn’s disease and ulcerative colitis are six of the most prevalent immune-mediated inflammatory diseases (IMIDs) and are associated with a high socio-economic impact. There is compelling evidence that IMIDs are gen...

Descripción completa

Detalles Bibliográficos
Autor: Aterido Ballonga, Adrià
Tipo de recurso: tesis doctoral
Estado:Versión publicada
Fecha de publicación:2019
País:España
Institución:CBUC, CESCA
Repositorio:TDR. Tesis Doctorales en Red
OAI Identifier:oai:www.tdx.cat:10803/666363
Acceso en línea:http://hdl.handle.net/10803/666363
Access Level:acceso abierto
Palabra clave:Immune mediated inflammatory diseases (IMIDs)
Genomics
Pharmacogenomics
Genome wide association study (GWAS)
Malalties inflamatòries mediades per immunitat (IMIDs)
Genòmica
Farmacogenòmica
Anàlisi d'associació de genoma complet (GWAS)
575
Descripción
Sumario:Rheumatoid arthritis, psoriasis, psoriatic arthritis, systemic lupus erythematosus, Crohn’s disease and ulcerative colitis are six of the most prevalent immune-mediated inflammatory diseases (IMIDs) and are associated with a high socio-economic impact. There is compelling evidence that IMIDs are genetically complex diseases. To date, however, the genetic component of IMIDs has been only partially explained. Identifying new clinically relevant variation is therefore of major clinical interest. The objective of the present thesis was to identify new genetic variation underlying IMIDs. The research activity here presented is the result of analyzing high-throughput genomic data from a large cohort of IMID patients collected by the IMID Consortium. Using genome-wide approaches and functional analyses, we have identified new genetic variants associated to IMID susceptibility, IMID clinical phenotypes and specific treatment outcomes. Taken together, these findings contribute to better understanding the genetic basis of IMIDs and suggest more specific and preventive therapeutic strategies.